They might easily be mistaken for Congressional staffers, reluctant to face the day, but these are among the most accomplished cancer specialists in the country, meeting with Representatives, Senators and staff. Among them: Dr. Elizabeth Jaffee, deputy director of the Johns Hopkins Kimmel Cancer Center, from up the road in Baltimore; and Dr. George Weiner, a cancer specialist in Iowa for more than 35 years, who has flown in frequently to lobby Congress for more research funds.
Main Idea: Trump administration budget cuts and layoffs are disrupting National Institutes of Health and National Cancer Institute cancer research, raising fears for patients in clinical trials.
Key Points:
Layoffs and NIH budget cuts could slow cancer research, delay clinical trials, and leave patients with fewer treatment options.
No clear positive impact identified.
Rate how each entity in this article affected the American people.
Core federal agency whose research funding and clinical trial ecosystem are a central subject of the article.
Central federal research body whose funding is being proposed for a major cut and whose grants and budget.
The administration proposing the budget cuts that are the main subject of the story.
Deputy director of the Johns Hopkins Kimmel Cancer Center and a central quoted researcher describing the impact of.
Named cancer specialist whose lobbying and warnings about research funding are a major part of the story.
Comments here are the same thread shown when this article appears in The Pulse.
No comments on this article yet.
Sign in to commentMajor research institution tied to Dr. Jaffee and the cancer research operation affected by funding cuts.
Cancer patient whose experience in a clinical trial is used to illustrate the stakes of NIH and National.
Another cancer patient introduced as a direct example of how proposed cuts could affect clinical trial access.
Family member of the patient who comments on the trial and taxpayer value, but is not a primary.
Mentioned as a colleague involved in the pancreatic cancer vaccine trial, but not a central voice in the.
The national context for federal cancer research funding and biomedical leadership discussed in the article.
Mentioned as Natalie Phelps' husband in the personal context of her cancer treatment and trial concerns.